A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
Clinical trial NCT05223101 · UNKNOWN
Trial details
- NCT number
- NCT05223101
- Sponsor
- HK inno.N Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2022-07-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.